grepcent public filings, reorganized for comparison

Jackson Financial Inc. (JXN)

CIK: 0001822993. SIC: 6311 Life Insurance. Latest 10-K as of: 2026-02-24.

SIC breadcrumb: Finance, Insurance, And Real Estate > Insurance Carriers > SIC 6311 Life Insurance

SEC company page: https://www.sec.gov/edgar/browse/?CIK=1822993. Latest filing source: 0001822993-26-000022.

Informational only. Descriptive public-record data — not a rating, forecast, or investment advice. See Disclaimer.

At a glance

FY2025 · period end 2025-12-31 · filed 2026-02-24 · accession 0001822993-26-000022 · source: SEC companyfacts

Revenue
6,683,000,000 USD verified
Net income
27,000,000 USD verified
Assets
352,586,000,000 USD verified
Net margin
0.40% computed
Revenue YoY
+104.31% computed
ROE
0.27% computed

Computed values are grepcent-computed from the verified facts above and may differ from ratios the company itself reports. Net margin = net income ÷ revenue. Revenue YoY = FY2025 revenue ÷ FY2024 revenue − 1 (consecutive fiscal years only). ROE = net income ÷ period-end stockholders' equity.

Peer groups: Life insurers · SIC 6311 Life Insurance

No market price, no rating, no forecast on this site. Not investment advice.

Peer & cluster context

Peer comparisons including JXN

Peer percentile fingerprint

JXN ratios vs SIC peers. Source: grepcent computed from latest SEC companyfacts ratios; peer set SIC industry 6311; per-ratio N printed.JXN ratios vs SIC peers. Source: grepcent computed from latest SEC companyfacts ratios; peer set SIC industry 6311; per-ratio N printed.RatioJXNPeer medianPercentileNNet margin0.4%5.7%813Revenue growth104.3%3.7%10013ROE0.3%8.8%813ROA0.0%0.4%813Liabilities / equity34.3922.767513

Percentile = share of the N covered peers reporting that ratio whose value is lower (ties counted half); computed among grepcent-covered companies in SIC industry 6311 Life Insurance, not the whole market. A higher percentile means a higher value of the ratio, not a better company. Ratios with fewer than 8 reporting peers are omitted. Latest reported values per company; fiscal periods may differ. Descriptive arithmetic - not a score, rating, or ranking.

Selected Fundamentals

MetricValueUnitFYFiled
Revenue6,683,000,000USD20252026-02-24
Net income27,000,000USD20252026-02-24
Assets352,586,000,000USD20252026-02-24

Financials

Annual standardized facts from SEC companyfacts as of latest extracted filing date 2026-02-24. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001822993.json. Derived margins, ratios, and free cash flow are computed from the extracted annual SEC facts.

Download these verified figures (annual + quarterly, with per-value filing provenance): JSON · CSV

Flow metrics use full-year FY periods from 10-K/10-K/A filings; balance-sheet metrics use FY-end instants. Free cash flow = operating cash flow - capital expenditures. Missing metrics are omitted rather than fabricated.

Metric2019202020212022202320242025
Revenue3,478,000,0003,546,000,0006,360,000,0009,848,000,0003,083,000,0003,271,000,0006,683,000,000
Net income-497,000,000-1,634,000,0003,417,000,0006,186,000,000934,000,000946,000,00027,000,000
Diluted EPS-13.16-24.1436.1769.7510.7611.74-0.24
Operating cash flow4,368,000,0003,712,000,0005,682,000,0005,206,000,0005,310,000,0005,793,000,0005,758,000,000
Dividends paid0.000.0050,000,000186,000,000201,000,000211,000,000223,000,000
Share buybacks0.000.00211,000,000321,000,000306,000,000442,000,000669,000,000
Assets355,511,000,000375,559,000,000314,983,000,000330,255,000,000338,450,000,000352,586,000,000
Liabilities348,576,000,000364,485,000,000305,605,000,000319,921,000,000328,468,000,000342,244,000,000
Stockholders' equity9,429,000,00010,394,000,0008,646,000,00010,170,000,0009,764,000,0009,953,000,000
Cash and cash equivalents1,935,000,0002,019,000,0002,623,000,0004,298,000,0002,688,000,0003,767,000,0005,704,000,000

Ratios

ROE and ROA use period-end equity/assets. Liabilities / equity uses total liabilities divided by stockholders' equity. Current ratio uses current assets divided by current liabilities when both are reported.

Metric2019202020212022202320242025
Net margin-14.29%-46.08%53.73%62.81%30.30%28.92%0.40%
Return on equity-17.33%32.87%71.55%9.18%9.69%0.27%
Return on assets-0.46%0.91%1.96%0.28%0.28%0.01%
Liabilities / equity36.9735.0735.3531.4633.6434.39

Industry Peer Context

Each number-line places JXN against the min, median, and max of latest reported values among companies in the same SIC industry when at least three peers report that ratio.

Net margin peer context

JXN Net margin versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 6311; peer count 13.JXN Net margin versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 6311; peer count 13.13 SIC peersMin -2.0%Median 5.7%Max 22.8%JXN 0.4%

ROE peer context

JXN ROE versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 6311; peer count 13.JXN ROE versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 6311; peer count 13.13 SIC peersMin -2.8%Median 8.8%Max 30.7%JXN 0.3%

ROA peer context

JXN ROA versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 6311; peer count 13.JXN ROA versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 6311; peer count 13.13 SIC peersMin -0.1%Median 0.4%Max 5.0%JXN 0.0%

Financial Charts

JXN revenue, last 5 periods. Source: SEC companyfacts FY2025.JXN revenue, last 5 periods. Source: SEC companyfacts FY2025.JXN RevenueLatest point: FY2025 = $6.7BSource: SEC companyfacts FY2025.Fiscal yearReported revenue$0.0B$5.0B$10.0BFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001822993-26-000022; filed 2026-02-24. Concept: Revenues. Source concepts: us-gaap:Revenues.

JXN net income, last 5 periods. Source: SEC companyfacts FY2025.JXN net income, last 5 periods. Source: SEC companyfacts FY2025.JXN Net incomeLatest point: FY2025 = $27.0MSource: SEC companyfacts FY2025.Fiscal yearNet income$0.0B$4.0B$8.0BFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001822993-26-000022; filed 2026-02-24. Concept: NetIncomeLoss. Source concepts: us-gaap:NetIncomeLoss.

JXN diluted eps, last 5 periods. Source: SEC companyfacts FY2025.JXN diluted eps, last 5 periods. Source: SEC companyfacts FY2025.JXN Diluted EPSLatest point: FY2025 = -$0.24/shareSource: SEC companyfacts FY2025.Fiscal yearDiluted EPS (USD/share)-$0.50/share$0.00/share$80.00/shareFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001822993-26-000022; filed 2026-02-24. Concept: EarningsPerShareDiluted. Source concepts: us-gaap:EarningsPerShareDiluted.

JXN operating cash flow, last 5 periods. Source: SEC companyfacts FY2025.JXN operating cash flow, last 5 periods. Source: SEC companyfacts FY2025.JXN Operating cash flowLatest point: FY2025 = $5.8BSource: SEC companyfacts FY2025.Fiscal yearOperating cash flow$0.0B$3.0B$6.0BFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001822993-26-000022; filed 2026-02-24. Concept: NetCashProvidedByUsedInOperatingActivities. Source concepts: us-gaap:NetCashProvidedByUsedInOperatingActivities.

JXN dividends paid, last 5 periods. Source: SEC companyfacts FY2025.JXN dividends paid, last 5 periods. Source: SEC companyfacts FY2025.JXN Dividends paidLatest point: FY2025 = $223.0MSource: SEC companyfacts FY2025.Fiscal yearDividends paid$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001822993-26-000022; filed 2026-02-24. Concept: PaymentsOfDividendsCommonStock. Source concepts: us-gaap:PaymentsOfDividendsCommonStock.

JXN share buybacks, last 5 periods. Source: SEC companyfacts FY2025.JXN share buybacks, last 5 periods. Source: SEC companyfacts FY2025.JXN Share buybacksLatest point: FY2025 = $669.0MSource: SEC companyfacts FY2025.Fiscal yearShare buybacks$0.0B$375.0M$750.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001822993-26-000022; filed 2026-02-24. Concept: PaymentsForRepurchaseOfCommonStock. Source concepts: us-gaap:PaymentsForRepurchaseOfCommonStock.

JXN assets, last 5 periods. Source: SEC companyfacts FY2025.JXN assets, last 5 periods. Source: SEC companyfacts FY2025.JXN AssetsLatest point: FY2025 = $352.6BSource: SEC companyfacts FY2025.Fiscal yearAssets$0.0B$200.0B$400.0BFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001822993-26-000022; filed 2026-02-24. Concept: Assets. Source concepts: us-gaap:Assets.

JXN liabilities, last 5 periods. Source: SEC companyfacts FY2025.JXN liabilities, last 5 periods. Source: SEC companyfacts FY2025.JXN LiabilitiesLatest point: FY2025 = $342.2BSource: SEC companyfacts FY2025.Fiscal yearLiabilities$0.0B$200.0B$400.0BFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001822993-26-000022; filed 2026-02-24. Concept: Liabilities. Source concepts: us-gaap:Liabilities.

JXN stockholders' equity, last 5 periods. Source: SEC companyfacts FY2025.JXN stockholders' equity, last 5 periods. Source: SEC companyfacts FY2025.JXN Stockholders' equityLatest point: FY2025 = $10.0BSource: SEC companyfacts FY2025.Fiscal yearStockholders' equity$0.0B$10.0B$20.0BFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001822993-26-000022; filed 2026-02-24. Concept: StockholdersEquity. Source concepts: us-gaap:StockholdersEquity.

JXN cash and cash equivalents, last 5 periods. Source: SEC companyfacts FY2025.JXN cash and cash equivalents, last 5 periods. Source: SEC companyfacts FY2025.JXN Cash and cash equivalentsLatest point: FY2025 = $5.7BSource: SEC companyfacts FY2025.Fiscal yearCash and cash equivalents$0.0B$3.0B$6.0BFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001822993-26-000022; filed 2026-02-24. Concept: CashAndCashEquivalentsAtCarryingValue. Source concepts: us-gaap:CashAndCashEquivalentsAtCarryingValue.

As-reported value updates

9 tracked differences above grepcent's stated thresholds were found between the earliest XBRL-filed value and the value currently on file for the same fiscal period.

View the filing-by-filing ledger →

Quarterly

Quarterly standardized facts from SEC companyfacts as of latest extracted filing date 2026-08-03. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001822993.json.

Flow metrics use discrete quarter-length periods from 10-Q/10-Q/A filings. Q4 revenue and net income are derived only when annual FY and nine-month YTD facts exist for the same fiscal year; derived Q4 values are labeled. EPS Q4 is not derived.

QuarterEnd DateRevenueNet IncomeDiluted EPSMethod
2022-Q32022-09-3016.83reported discrete quarter
2023-Q12023-03-31-18.11reported discrete quarter
2023-Q22023-06-3014.21reported discrete quarter
2023-Q32023-09-302,606,000,0002,773,000,00033.35reported discrete quarter
2023-Q42023-12-31892,000,000-1,559,000,000derived Q4 = FY annual - nine-month YTD
2024-Q12024-03-31795,000,0009.94reported discrete quarter
2024-Q22024-06-301,247,000,000275,000,0003.43reported discrete quarter
2024-Q32024-09-302,121,000,000-469,000,000-6.37reported discrete quarter
2024-Q42024-12-31225,000,000345,000,000derived Q4 = FY annual - nine-month YTD
2025-Q12025-03-313,750,000,000-24,000,000-0.48reported discrete quarter
2025-Q22025-06-30179,000,0002.34reported discrete quarter
2025-Q32025-09-301,416,000,00076,000,0000.92reported discrete quarter
2025-Q42025-12-311,988,000,000-204,000,000derived Q4 = FY annual - nine-month YTD
2026-Q12026-03-312,902,000,000-424,000,000-6.24reported discrete quarter
2026-Q22026-06-30168,000,000655,000,0009.16reported discrete quarter

Quarterly Charts

JXN quarterly revenue, last 10 periods. Source: SEC companyfacts 2026-Q2.JXN quarterly revenue, last 10 periods. Source: SEC companyfacts 2026-Q2.JXN Quarterly RevenueLatest point: 2026-Q2 = $168.0MSource: SEC companyfacts 2026-Q2.Fiscal quarterQuarterly Revenue$0.0B$2.0B$4.0B2023-Q32023-Q42024-Q22024-Q32024-Q42025-Q12025-Q32025-Q42026-Q12026-Q2

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0001822993-26-000124; filed 2026-08-03. Concept: Revenues. Source concepts: us-gaap:Revenues.

JXN quarterly net income, last 12 periods. Source: SEC companyfacts 2026-Q2.JXN quarterly net income, last 12 periods. Source: SEC companyfacts 2026-Q2.JXN Quarterly Net incomeLatest point: 2026-Q2 = $655.0MSource: SEC companyfacts 2026-Q2.Fiscal quarterQuarterly Net income-$2.0B$0.0B$4.0B2023-Q32023-Q42024-Q12024-Q22024-Q32024-Q42025-Q12025-Q22025-Q32025-Q42026-Q12026-Q2

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0001822993-26-000124; filed 2026-08-03. Concept: NetIncomeLoss. Source concepts: us-gaap:NetIncomeLoss.

JXN quarterly diluted eps, last 12 periods. Source: SEC companyfacts 2026-Q2.JXN quarterly diluted eps, last 12 periods. Source: SEC companyfacts 2026-Q2.JXN Quarterly Diluted EPSLatest point: 2026-Q2 = $9.16/shareSource: SEC companyfacts 2026-Q2.Fiscal quarterQuarterly Diluted EPS (USD/share)-$20.00/share$0.00/share$40.00/share2022-Q32023-Q12023-Q22023-Q32024-Q12024-Q22024-Q32025-Q12025-Q22025-Q32026-Q12026-Q2

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0001822993-26-000124; filed 2026-08-03. Concept: EarningsPerShareDiluted. Source concepts: us-gaap:EarningsPerShareDiluted.

Business

Read JXN's verbatim Item 1 Business section from its latest 10-K: Business.

Risk Factors

Read JXN's verbatim Item 1A Risk Factors from its latest 10-K: Risk Factors.

Latest quarter (10-Q)

Latest 10-Q source: 0001822993-26-000124.

Extracted structurally from real Item 2 body heading to real Item 3/4 boundary. Confidence: high. Filing date: 2026-08-03. Report date: 2026-06-30.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

FORWARD-LOOKING STATEMENTS – CAUTIONARY LANGUAGE

The information in this Quarterly Report on Form 10-Q (this “report”) contains forward-looking statements about future events and circumstances and their effects upon revenues, expenses and business opportunities. Generally speaking, any statement in this report not based upon historical fact is a forward-looking statement. Forward-looking statements can also be identified by the use of forward-looking or conditional words, such as “could,” “should,” “can,” “continue,” “estimate,” “forecast,” “intend,” “look,” “may,” “expect,” “believe,” “anticipate,” “plan,” “predict,” “remain,” “future,” “confident,” and “commit” or similar expressions. In particular, statements regarding plans, strategies, prospects, targets and expectations regarding the business and industry are forward-looking statements. They reflect expectations, are not guarantees of performance and speak only as of the dates the statements are made. We caution investors that these forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially from those projected, expressed, or implied. Other factors that could cause actual results to differ materially from those in the forward-looking statements include those reflected in Part I, Item 1A. Risk Factors and Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended December 31, 2025, as filed with the U.S. Securities and Exchange Commission (the "SEC") on February 24, 2026, (the "2025 Annual Report"), and elsewhere in Jackson Financial Inc.’s reports filed with the SEC. Except as required by law, Jackson Financial Inc. does not undertake to update such forward-looking statements. You should not rely unduly on forward-looking statements.

Certain financial data included in this report consists of non-GAAP (Generally Accepted Accounting Principles) financial measures. These non-GAAP financial measures may not be comparable to similarly titled measures presented by other entities, nor should they be construed as an alternative to other financial measures determined in accordance with U.S. GAAP. Although the Company believes these non-GAAP financial measures provide useful information to investors in measuring the financial performance and condition of its business, investors are cautioned not to place undue reliance on any non-GAAP financial measures and ratios included in this report. A reconciliation of the non-GAAP financial measures to the most directly comparable U.S. GAAP financial measure can be found in the “Non-GAAP Financial Measures” in this report.

Certain financial data included in this report consists of statutory accounting principles (“statutory”) financial measures. These statutory financial measures are included in or derived from the Jackson National Life Insurance Company annual and/or quarterly statements filed with the Michigan Department of Insurance and Financial Services and are available in the investor relations section of the Company’s website at investors.jackson.com/financials/statutory-filings.

86

Item 2 | Management’s Discussion and Analysis | Available Information & Principal Definitions

Available Information

We make available free of charge, through our website, investors.jackson.com, our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, our proxy and information statements, and any amendments to those reports or statements as soon as reasonably practicable after these materials are electronically filed with, or furnished to, the SEC. The SEC’s website, www.sec.gov, contains financial reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC.

We routinely use the investor relations page of our website, investors.jackson.com, as a primary channel for dissemination of important information, including news releases, analyst presentations, financial information, insider beneficial owner reports, and corporate governance information. We may use our website as a means of disclosing material, non-public information and for complying with our disclosure obligations. Accordingly, investors should monitor our investor relations website, in addition to following our press releases, filings with the SEC, public conference calls, presentations, and webcasts. We and certain of our senior executives may also use social media channels to communicate with our investors and the public about our Company and other matters, and those communications could be deemed to be material information. None of the content of Jackson’s website, jackson.com, the content of our social media channels or the content of our executives’ social media channels is incorporated by reference into this report or in any other report or document filed with the SEC, and any references to Jackson’s website are intended to be inactive textual references only.

Principal Definitions, Abbreviations, and Acronyms Used in the Text and Notes of this Report

we, us, our and the CompanyJackson Financial Inc. and its consolidated subsidiaries, unless the context refers only to Jackson Financial Inc. as a corporate entity (which we refer to as "JFI" or "Jackson Financial")
JacksonJackson National Life Insurance Company, ("Jackson National Life") our primary operating subsidiary and its insurance subsidiaries (collectively "Jackson") (which we refer to as "Jackson National Life" or "Jackson")
Brooke LifeBrooke Life Insurance Company, our subsidiary and the direct parent company of Jackson and Brooke Re
Brooke ReBrooke Life Reinsurance Company, a direct subsidiary of Brooke Life, and a Michigan-based captive reinsurer
Hickory ReHickory Brooke Reinsurance Company, a direct subsidiary of Brooke Re, and a Michigan-based captive reinsurer
Jackson FinanceJackson Finance LLC, our subsidiary
JNAMJackson National Asset Management LLC, a direct subsidiary of Jackson National Life
PPMHPPM Holdings, Inc., our subsidiary
PPMPPM America, Inc., a subsidiary of PPMH
ACLAllowance for credit loss
Account value ("AV") or account balanceThe amount of money in a customer’s account. For example, the account value increases with additional premiums and investment gains, and it decreases with withdrawals, investment losses and fees.
AtheneAthene Life Re Ltd. and its affiliates, including Athene Co-Invest Reinsurance Affiliate 1A Ltd.
Athene Reinsurance TransactionThe funds withheld coinsurance agreement with Athene, entered on June 18, 2020, and effective June 1, 2020, to reinsure a 100% quota share of a block of our in-force fixed and fixed index annuity liabilities in exchange for approximately $1.2 billion in ceding commissions
AUM ("Assets under management")Investment assets that are managed by our subsidiaries and include: (i) assets managed by PPM, including our investment portfolio (but excluding assets held in funds withheld accounts for reinsurance transactions), (ii) third-party assets, and (iii) the separate account assets of our retail annuities managed and administered by JNAM

87

Item 2 | Management’s Discussion and Analysis | Available Information & Principal Definitions

[Excerpt truncated for page length; source filing is linked above.]

Latest 10-K MD&A (excerpt)

Latest 10-K Item 7 source: 0001822993-26-000022. The complete FY 2025 MD&A is published at /company/JXN/mda/fy2025/.

Extracted from Item 7 to the first post-MD&A boundary after HTML sanitization. Confidence: high. Filing date: 2026-02-24. Report date: 2025-12-31.

Part II | Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations |

Critical Accounting Estimates

In addition to the review procedures described above, investments in asset-backed securities where market prices are depressed are subject to a review of their future estimated cash flows, including expected and stress case scenarios, to identify potential shortfalls in contractual payments. These estimated cash flows are developed using available performance indicators from the underlying assets including current and projected default or delinquency rates, levels of credit enhancement, current subordination levels, vintage, expected loss severity and other relevant characteristics. These estimates reflect a combination of data derived by third parties and internally developed assumptions. Where possible, this data is benchmarked against third-party sources.

For mortgage-backed securities, credit losses are assessed using a cash flow model that estimates the cash flows on the underlying mortgages, using the security-specific collateral characteristics and transaction structure. The model estimates cash flows from the underlying mortgage loans and distributes those cash flows to various tranches of securities, considering the transaction structure and any subordination and credit enhancements existing in that structure. The cash flow model incorporates actual cash flows on the mortgage-backed securities through the current period and then projects the remaining cash flows using a number of assumptions, including prepayment speeds, default rates and loss severity. Specifically, for prime and Alt-A RMBS, the assumed default percentage is dependent on the severity of delinquency status, with foreclosures and real estate owned receiving higher rates, but also includes the currently performing loans. These estimates reflect a combination of data derived by third parties and internally developed assumptions. Where possible, this data is benchmarked against other third-party sources. In addition, these estimates are extrapolated along a default timing curve to estimate the total lifetime pool default rate.

After these reviews, we recognize impairments on debt securities in an unrealized loss position when any of the following circumstances exists:

•We intend to sell a security;

•It is more likely than not that we will be required to sell a security prior to recovery; or

•We do not expect full recovery of the amortized cost based on the discounted cash flows estimated to be collected.

Mortgage loans, which are not carried at fair value under the fair value option, are carried at the aggregate unpaid principal balance, adjusted for any applicable unamortized discount or premium, or ACL. Acquisition discounts and premiums on mortgage loans are amortized into investment income through maturity dates using the effective interest method. Interest income is accrued on the principal balance of the loan based on the loan’s contractual interest rate. Interest income and amortization of premiums and discounts are reported in net investment income along with prepayment fees and mortgage loan fees, which are recorded as incurred.

We review mortgage loans on a quarterly basis to estimate the ACL with changes in the ACL recorded in net gains (losses) on derivatives and investments. Apart from an ACL recorded on individual mortgage loans where the borrower is experiencing financial difficulties, we record an ACL on the pool of mortgage loans based on lifetime expected credit losses. Credit loss estimates are pooled by property type and unfunded commitments are included in the model with an allowance for credit losses determined accordingly.

Mortgage loans on real estate deemed uncollectible are charged against the ACL, and subsequent recoveries, if any, are credited to the ACL.

Accrued interest receivables are presented separate from the amortized cost of debt securities and mortgage loans. An allowance for credit losses is not estimated on an accrued interest receivable. Rather, receivable balances that are deemed uncollectible are written off with a corresponding reduction to net investment income.

Derivatives

Freestanding Derivative Instruments

We enter into financial derivative transactions, including swaps, put-swaptions, futures, forwards, and options to reduce and manage business risks. These transactions manage the risk of a change in the value, yield, price, cash flows, foreign currency, credit quality or degree of exposure with respect to assets, liabilities or future cash flows that we have acquired or incurred.

91

Part II | Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations |

Critical Accounting Estimates

Freestanding derivative instruments are reported at fair value, which reflects the estimated amounts, net of payment accruals, that we would receive or pay upon sale or termination of the contracts at the reporting date. Freestanding derivatives priced using third party pricing services incorporate inputs that are predominantly observable in the market. The determination of the estimated fair value of freestanding derivatives, when quoted market values are not available, is based on market standard valuation methodologies and inputs that management believes are consistent with what other market participants would use when pricing such instruments. Derivative valuations can be affected by changes in interest rates, foreign currency exchange rates, financial indices, credit spreads, default risk, non-performance risk, volatility, liquidity and changes in estimates and assumptions used in the pricing models. See Item 8. Financials Statements and Supplementary Data — Note 5 - Derivative Instruments and Note 6 - Fair Value Measurements of the Notes to Consolidated Financial Statements for additional information on significant inputs into our derivative pricing methodology.

Embedded Derivatives - Product Liabilities

For our registered index-linked and fixed index annuities, the equity-linked option issued by the Company is accounted for at fair value as an embedded derivative on the Company’s Consolidated Balance Sheets as a component of other contract holder funds, with changes in fair value recorded in net income.

The fair value of the embedded derivative for the FIA and RILA products is determined using an option-budget method with capital market inputs of market index returns and discount rates as well as actuarial assumptions including lapse, mortality and withdrawal rates. We typically update our actuarial assumptions annually as discussed above, unless a material change is observed in an interim period that we feel is indicative of a long-term trend.

The underlying assumptions may have a material impact on the measurement of the embedded derivative, including equity market movements.

See Item 8. Financials Statements and Supplementary Data — Note 5 - Derivative Instruments and Note 10 - Other Contract Holder Funds of the Notes to Consolidated Financial Statements for additional information on our accounting policies for embedded derivatives bifurcated for insurance host contracts.

Embedded Derivatives - Funds Withheld Reinsurance Agreements

The Company has recorded an embedded derivative liability related to the Athene coinsurance agreement (the “Athene Embedded Derivative”) in accordance with ASC 815-15 as Jackson’s obligation under the coinsurance agreement is based on the total return of investments in a segregated funds withheld account. As the coinsurance agreement transfers the performance of the investments in the segregated funds withheld account to Athene, they will receive an investment return equivalent to owning the underlying assets. At inception of the coinsurance agreement, the Athene Embedded Derivative was valued at zero. Additionally, the inception fair value of the investments in the segregated funds withheld account differed from their book value and, accordingly, the amortization of this difference is reported in Net gains (losses) on derivatives and investments in the Consolidated Income Statement, while the investments are held. Subsequent to the effective date of the coinsurance agreement, the Athene Embedded Derivative is measured at fair value with changes reported in Net gains (losses) on derivatives and investments in the Consolidated Income Statement. The Athene Embedded Derivative Liability is included in Funds withheld payable under reinsurance treaties on the Consolidated Balance Sheet.

See Item 8. Financial Statements and Supplementary Data — Note 8 - Reinsurance of the Notes to Consolidated Financial Statements for additional information on Athene Reinsurance Transaction.

Net Investment Income

Net investment income reported for each of our three segments and Corporate and Other includes an allocation for investment income generated on assigned capital. The amount of capital assigned to each of our segments for purposes of measuring segment net investment income is established at a level that management considers necessary to support the segment’s risks. This assessment is determined based upon internal models and contemplates the RBC requirements at internally defined levels. Net investment income on capital in excess of the amount required to support our core operating strategies is reflected in Corporate and Other.

92

Part II | Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations |

Critical Accounting Estimates

Contingent Liabilities

We are a party to legal actions and, at times, regulatory investigations. Given the inherent unpredictability of these matters, it is difficult to estimate their impact on our financial position. A reserve is established for contingent liabilities if it is probable that a loss has been incurred and the amount is reasonably estimable. It is possible that an adverse outcome in certain of our contingent liabilities, or the use of different assumptions in the determination of amounts recorded, could have a material effect upon our financial position. However, it is the opinion of management that the ultimate disposition of contingent liabilities is unlikely to have a material adverse effect on our financial position.

Consolidation of Variable Interest Entities (“VIEs”)

The Company invests in a number of asset types that may be VIEs, such as equity positions in collateralized loan obligations (“CLOs”), limited partnerships (“LPs”), limited liability companies (“LLCs”), and mutual funds. These entities are assessed to determine whether they meet the criteria as a VIE. The Company consolidates VIEs where the Company has determined that it is the primary beneficiary of the VIE. To the extent that external parties are also invested in these VIEs, a non-controlling interest is reflected on our Consolidated Financial Statements as well. See Item 8. Financial Statements and Supplementary Data — Note 4 - Investments of the Notes to Consolidated Financial Statements for additional information.

93

Part II | Item 7A. Quantitative and Qualitative Disclosures about Market Risk

Read the full FY 2025 MD&A or browse all MD&A years.

MD&A history

Prior-year 10-K MD&A spans are extracted from SEC filings with the same bounded parser used for the latest filing. Each year's full verbatim text is on its own sub-page.

Macro cross-references for JXN

Indicators mapped to this company's SIC classification (industry 6311 Life Insurance) by grepcent's deterministic macro-sector crosswalk. A navigational mapping, not a statistical or causal claim.

Macro-to-micro threads including this sector: Money & trade, Government finances, Sector employment.

All 71 macro indicators →

For LLMs & downloads

Markdown twin: /company/JXN.md · JSON record: /company/JXN.json · verified financials: JSON / CSV · machine TOC for the whole site: /llms.txt